乌鸦传媒

Low rates of toxicity and salvage cystectomy, with 2-year survival similar to surgery

Each of these specialties average over $500k per year

Latest negative results emphasize "critical" aspect of immunotherapy timing

With 98% PFS at 2 years, standard RT plus cisplatin sets a higher bar for de-escalation

Trial finds similar complication and recurrence rates with hypofractionated versus standard RT

Numerical advantage in randomized trial, non-randomized study misses noninferiority mark

In three trials, about 40% of patients with brain metastases recovered neurocognitive function

"It really shows us that we have two great options," expert says

"Nodal radiotherapy for breast cancer no longer needs 5 weeks," researcher says

Survival similar to resection with less morbidity, but editorial suggests use in select patients

A study's 30-year follow-up data provided no new insights into which patients benefit from RT

Fourfold improvement in median PFS when added to standard-of-care systemic therapy

High success rate, few adverse events in patients ineligible for initial trials

A third of patients who had received multiple prior lines of therapy responded, small study shows